Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Ciprofloxacin

Research Leaders

20 sponsors active, led by Assiut University

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
Phase 4 (2)

Trial Status

Completed5
Not Yet Recruiting1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Ciprofloxacin1
  • Endoscopic Ureteric Lithotripsy1
  • Tenoxicam1
  • No Doublej Catheter Insertion1
  • Acetaminophen1

Active Sponsors

  • Assiut University1
  • Robert Swor1
  • Tallaght University Hospital1
  • University Hospital, Basel, Switzerland1
  • Centre de recherche du Centre hospitalier universitaire de Sherbrooke1

Top Investigators

Related Conditions

  • Kidney Stones2
  • Ureteroscopic Lithotripsy1
  • Ureteral Calculi1
  • Nephrolithiasis1
  • Urolithiasis1

Activity Timeline